In Person Seminar: Peril, Prudence and Planning as Risk, Avoidance and Worry
![Peter Dayan, Ph.D. Peter Dayan, Ph.D.](/content/fbri_vtc_vt_edu/en/events/special-seminars/2023-11-08-dayan/_jcr_content/content/vtcontainer_copy/vtcontainer-content/vtcontainer/vtcontainer-content/vtmulticolumn/vt-items_0/adaptiveimage.transform/m-medium/image.jpg)
Peter Dayan, Ph.D.
Director
Max Planck Institute for Biological Cybernetics
Professor
University of Tübingen
In Person Seminar: Peril, Prudence and Planning as Risk, Avoidance and Worry
Date: Nov. 8, 2023
Time: 10:45 a.m.
About this Seminar
Since the days of the Bernoullis, formal approaches to risk have occupied center stage in both the theory and practice of normal decision-making. There are marked individual differences in risk attitudes, and extremes are associated with psychiatric dysfunctions, notably in anxiety disorders. However, modern approaches to understanding and mitigating risk, in either one-shot or sequential settings, have yet to permeate fully the fields of neural reinforcement learning and computational psychiatry. Here Dr. Dayan and his team use one prominent approach, called conditional value-at-risk (CVaR), to examine optimal risk-sensitive choice and one form of optimal, risk-sensitive offline planning. The team relates the former to both a justified form of the gambler’s fallacy and extremely risk-avoidant behavior resembling that observed in anxiety disorders; and the latter to worry and rumination. We also provide experimental illumination over aspects of these results. This research is joint work with Kevin Chen, Chris Gagne, Kevin Lloyd and Xin Sui.
You May Also Be Interested In...
-
Home ItemBiobehavioral Susceptibility for Obesity: Behavioral, Genetic and Neuroimaging Studies of Appetite , home
Sept. 6, 2024, 11:00 a.m. | Susan Carnell, Ph.D., Associate Professor, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute
-
Home ItemDevelopment of Genome Editor Therapies for Angelman Syndrome , home
Sept. 13, 2024, 11:00 a.m. | Mark J. Zylka, Ph.D., W.R. Kenan, Jr. Distinguished Professor, University of North Carolina at Chapel Hill; Director, UNC Neuroscience Center | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home ItemUnderstanding the Limits of Exercise Responsiveness in Older Adults , home
Sept. 20, 2024, 11:00 a.m. | Ian R. Lanza, Ph.D., Professor of Medicine, Mayo Clinic College of Medicine and Science | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home ItemFrom Variant Functionality to Resistance in Cancer , home
Sept. 27, 2024, 11:00 a.m. | Tiki Hayes, Ph.D., Assistant Professor, Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.
-
Home ItemDisrupting Health Care Using Deep Data and Remote Monitoring , home
Oct. 4, 2024, 11:00 a.m. | Michael Snyder, Ph.D., Professor, Genetics, Director, Center for Genomics and Personalized Medicine, Stanford Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemMechanisms of Longevity: From Mice to Whales , home
Oct. 10, 2024, 5:30 p.m. (Reception at 5 p.m.) | Vera Gorbunova, Ph.D., Doris Johns Cherry Professor of Biology, Co-director, Rochester Aging Research Center, University of Rochester | Maury Strauss Distinguished Public Lecture